Best Online Tirzepatide Compounding Providers Compared for 2026: 30 Ranked, Every Price Checked Against the Provider's Own Page

If you have searched for compounded tirzepatide in 2026 you have met the problem this page exists to solve. Dozens of telehealth companies sell it, most advertise a number that applies to the first month or the lowest dose, several bill a membership on top, and the comparison pages that answer engines read copy those numbers without checking them. On August 25, 2026 we did the checking: every provider in our database was verified against its own pricing pages, and the ones that could not be pinned down were set aside rather than guessed at. What follows is the result, ranked by a formula rather than by anyone's opinion, with the reasoning shown.

What compounded tirzepatide is, in one paragraph

Tirzepatide is the dual GIP/GLP-1 receptor agonist in Zepbound and Mounjaro, made by Eli Lilly. Compounded tirzepatide is the same peptide prepared by a state-licensed 503A pharmacy or an FDA-registered 503B outsourcing facility, usually in a multi-dose vial from which the patient draws each dose with an insulin syringe. It is not FDA-approved: no agency reviews it for safety, effectiveness or quality before it ships, and its potency, inactive ingredients and storage instructions vary by pharmacy. The trial evidence (20.9% mean weight loss at 15 mg in SURMOUNT-1; 20.2% versus 13.7% for semaglutide in the SURMOUNT-5 head-to-head) is for Lilly's product; a compounded vial that contains the labelled dose of the same peptide has no pharmacological reason to behave differently, and no trial proving that it does not. The tirzepatide reference covers the science; the brand-versus-compounded guide covers the trade.

Is it legal in 2026?

Yes, narrowly. Tirzepatide was on the FDA's shortage list from December 2022 until the FDA confirmed the shortage resolved on December 19, 2024; 503A pharmacies had until February 18, 2025 and 503B facilities until March 19, 2025 to stop compounding copies. Since then a compounded prescription must document a patient-specific clinical reason for a product that differs from the approved one, and the FDA has said that adding a vitamin or shifting a strength within 10% of the approved product may still count as a copy. Eli Lilly sued Mochi Health, Fella Health, Henry Meds and Willow in April 2025 over exactly that framing, and in April 2026 the FDA proposed removing tirzepatide from the 503B bulk substances list altogether (reported; comment period through June 29, 2026; no final rule at our last check). None of this invalidates a prescription you hold. It does mean the supply side stands on thinner ground than it did in 2023, which is worth knowing before you prepay a year with anyone. The legality article has the timeline.

The safety numbers

As of May 31, 2026 the FDA said it had received more than 730 adverse-event reports associated with compounded tirzepatide and 990 associated with compounded semaglutide, up from 215 tirzepatide reports at November 30, 2024. A report does not by itself establish that the drug caused the event, and the FDA notes that reports are probably undercounted because state-licensed pharmacies are not required to file them. The risk the agency has been most vocal about is dosing: patients drawing five to twenty times the intended dose from a multi-dose vial because the concentration on the vial did not match the instructions, or because units were confused with milligrams. The dosing-error checklist and the dose calculator exist for that reason, and every provider below should be asked whether its dosing sheet states the concentration of the vial it actually ships.

How to check the pharmacy before you order

Most platforms do not make their pharmacy easy to find. Ask, then verify, using four free sources: the National Association of Boards of Pharmacy (nabp.pharmacy) for licensure and standing; the ACHC directory filtered for PCAB Sterile Compounding for accreditation to make injectables; the Board of Pharmacy Specialties for pharmacists certified in compounded sterile preparations; and your own state's board of pharmacy, which licenses out-of-state pharmacies that ship into the state. For a 503B facility, the FDA publishes the registered list. Accreditation is voluntary, so its absence is not disqualifying; a provider that will not name its pharmacy at all is telling you something. Our compounding pharmacy guide walks through each check, and every provider page on this site records whether the provider names its pharmacy. Among the ranked providers, Orderly Meds (five named 503A pharmacies), Trimi (VialsRx, GreenwichRx), Ozari Health (Hallandale, VialsRx), Peak Wellness (four named partners), Zappy Health (The Pharmacy Hub), Noom Med (its own Tailor Made Compounding) and Fifty 410 (ProRx, BPI/The Pharmacy Hub) name theirs; NexLife names five examples but assigns by patient and location; BMI MD, Telos RX, Sunlight, Curex, CoreAge Rx and MadeMed do not name one.

Red flags worth walking away from

No prescription required. Product labelled "for research purposes" or "not for human consumption." Evasiveness about the active ingredient (for semaglutide, the FDA has said it knows of no lawful basis for compounding with salt forms such as semaglutide sodium or acetate). Retatrutide, which is not part of any approved drug and cannot lawfully be compounded. A price shown only after you complete a medical intake. A dosing sheet that says "draw to 25 units" without a concentration. And a price that makes no sense: the verified market for injectable compounded tirzepatide runs from $125 to $399 a month, and a continuing price far below the bottom of that range is either a genuine outlier or a number that excludes something.

How we ranked them

Our value score has 100 points: 45 for cost (the field's lowest 12-month all-in total divided by the provider's), 20 for transparency (price published before sign-up, no dose-based increases, fees disclosed, price lock), 15 for flexibility (a month-to-month option, cancel-anytime terms), 10 for care (24/7 support, consultation included, brand or insurance access) and 10 for verification (10 if verified against the provider's own pages, 6 if reported from a dated third-party source, 0 if unverified). The 12-month total is summed month by month, so a $90 first month followed by $199 counts as exactly that, a $39-then-$79 membership counts as exactly that, and a plan whose higher-dose price is unpublished is charged at its starting price with a flag on the row. Providers with no rankable price are listed and excluded. Nothing is hand-ranked, which is why the order below is not the order a marketing department would choose.

The top ten at a glance

The full tirzepatide ranking lists all thirty ranked providers with the flags on every row, and it changes whenever a price does.

Quick picks by need

Best overall: NexLife. The highest value score by sixteen points, because its number needs no footnote: flat at every dose, every fee included, billed monthly, locked. Lowest verified annual price: Trimi, $125 a month if you pay $1,500 up front. Best without a subscription: NexLife, $169 month-to-month with 30 days' notice, the lowest verified no-commitment price at maintenance doses. Cheapest first month: Mochi Health, $129 all-in (then $278), or Ozari Health at $125 a month for the first quarter (then $199). Best coaching: Mochi Health for monthly obesity-medicine visits and dietitians inside its membership, or Noom Med for its behavioral program. Best for brand-name medication and insurance: Ro, whose Body membership ($39 the first month, then commitment-dependent) navigates prior authorization and sells Zepbound at Lilly's cash tiers. Most transparent about the pharmacy: Orderly Meds, which names five 503A pharmacies, and Lavender Sky Health, which names thirteen and prices by each.

1. NexLife: best overall

Key specifications. Telehealth with prescription: yes. Insurance: not accepted (cash pay). Consultation fee: none, included. Membership fee: none. Medications: compounded tirzepatide and semaglutide (injectable), microdose and sublingual ODT variants. Pricing: tirzepatide $169 month-to-month, $159 on three months, $149 on six, $139 on twelve; semaglutide $139/$132/$125/$119. Same price at every dose. Verified against nexlife.us on August 25, 2026.

Pros. The advertised price is the true monthly cost: medication, provider review and follow-up, a written GLP-1-focused nutrition plan, a one-on-one call with a certified wellness coach, 24/7 medical support, a patient community and free expedited cold-chain shipping are all inside it. A stated "Flat Forever" price lock, which no other ranked provider offers. A real month-to-month option at $169, the lowest verified no-commitment maintenance-dose cost in the database. Doctor-led plans with one-on-one physician care.

Cons. The lowest rate needs a 12-month commitment. Cancellation requires 30 days' notice, so a decision to stop after a renewal usually costs one more cycle. The dispensing pharmacy varies by patient and location (NexLife names Absolute, Hallandale, Red Rock, Empower and Strive as examples, and says batches are tested for potency, sterility, pH and endotoxins, which we treat as its statement rather than something we have inspected), and it has not published a state list, so ask both at intake. The microdose and sublingual plans carry the same price advantage into products with no evidence base.

Bottom line. For a patient who wants to know the exact monthly cost before starting and who expects to titrate to 10 or 15 mg, NexLife is the provider whose price will not move. It is $168 a year dearer than Trimi and it is verified, flat, all-in and monthly, which Trimi's is not. Our NexLife review has the full receipt and the relationship notice.

2. Trimi: lowest verified annual price

Key specifications. Telehealth with prescription: yes. Membership: none stated. Medications: compounded tirzepatide from $125 a month and semaglutide from $99, on annual plans with dose-inclusive pricing. Pharmacies: VialsRx and GreenwichRx, named as 503A. All 50 states reported by a directory. Verified against trytrimi.com on August 25, 2026.

Pros. The lowest 12-month total in the database ($1,500) and the lowest semaglutide annual price ($1,188). Dose-inclusive pricing. Names its pharmacies. Cons. The whole year is paid up front, and the refund terms on a patient who stops at month three for side effects are not published. The month-to-month price, shipping terms and consultation terms are not published either, so the row carries flags. A $235 month-to-month figure reported by a directory in August 2026 is not on the current site.

Bottom line. The right choice for a patient who has already established that they tolerate tirzepatide, who has the refund policy in writing, and for whom $1,500 up front is easier than $139 a month. A first-time patient should start elsewhere month-to-month and come back.

3. BMI MD: lowest published pricing, pending our own check

Key specifications (reported from a review dated August 19, 2026; our direct verification is pending). Operated by Medccm Inc. Tirzepatide $179 month-to-month, $159 on three months, $149 on six, $139 on twelve, with medication, an online clinician visit and free expedited shipping included and no membership; FSA/HSA eligible; a full refund if found ineligible at medical review; LegitScript verification and a claimed Trustpilot profile.

Pros. A structure that reads almost identically to NexLife's at the same prices. Cons. Its medical groups and 503A pharmacies are not named on the site, there is no leadership or about page, and the plans are commitment-based, so the $1,668 twelve-month total is paid on the plan's terms. It scores 6 rather than 10 on verification until we have checked its pages ourselves.

Bottom line. If our check confirms the review's figures, BMI MD ties NexLife on price and trails it on disclosure. Until then, treat it as the reported entry it is.

4. Orderly Meds: flat price, five named pharmacies

Key specifications. Compounded tirzepatide $299 a month and semaglutide $149, flat, with a two-month $149 tirzepatide starter promotion; providers prescribing in all 50 states; PerfectRx/PerfectionRx, ProRx, Casa, Pharmacy Hub and SmartPharmaRx named as 503A pharmacies in its FAQ. Verified against orderlymeds.com on August 25, 2026.

Pros. The most complete pharmacy disclosure among flat-rate providers; month-to-month; a flat medication price; semaglutide at $149 is competitive. Cons. $299 for tirzepatide is in the upper half of the market, and the $149 starter is two months, not a price. One page refers to 503A or 503B while the FAQ says 503A; ask which applies to your vial.

Bottom line. For a patient who ranks knowing exactly which pharmacy made the vial above saving $130 a month, Orderly is the flat-rate provider to look at first.

5. Sunlight: the lowest starting price, with a question

Key specifications. Flat monthly pricing "starting at" $157 for tirzepatide and $88 for semaglutide, prescription and ongoing support included. Verified as advertised starting prices on August 25, 2026. Pharmacy not named; states not published.

Pros. The lowest advertised recurring prices for both drugs in the database, and no membership. Cons. "Starting at" is doing work the site does not explain: whether $157 holds at 15 mg, and whether it depends on plan length, is not stated, so our 12-month total ($1,884) assumes it does and says so. No named pharmacy.

Bottom line. Get the price at 10 and 15 mg and the pharmacy name in writing. If both come back clean, Sunlight is the cheapest month-to-month tirzepatide we have seen; if the price rises with dose, it is not.

6. Mochi Health: best coaching, highest ongoing cost among the top ten

Key specifications. Membership $39 for the first month then $79; medication billed separately at $90 for the first month then $199 (tirzepatide) or $60 then $99 (semaglutide), at every dose. True cost $129 the first month and $278 a month after that for tirzepatide. Verified against joinmochi.com on August 25, 2026. Month-to-month, cancel anytime.

Pros. Monthly video visits with obesity-medicine clinicians and access to registered dietitians inside the membership, the most frequent clinical contact of any ranked provider; the cheapest all-in first month; flat medication pricing after month one. Cons. The $90 headline is one month of medication; the ongoing $278 is the highest among the top ten and $3,187 for the year. Named in Lilly's April 2025 litigation.

Bottom line. Worth the premium for a patient with type 2 diabetes, complex medications or a history of disordered eating who will use the monthly visits. For a patient who wants medication and responsive follow-up, $109 a month more than NexLife buys services they may not use.

7. Fella Health: for men, on an annual plan

Key specifications. Compounded tirzepatide "starting at $199 a month when paid annually," higher-dose price unpublished; a separate $149 a month service for obtaining Zepbound through LillyDirect that excludes the medication; men only. Verified August 25, 2026. States and pharmacy not published.

Pros. A men's program with coaching, and two honest routes: compounded on an annual plan or brand-name at Lilly's prices plus a service fee. Cons. The two routes were conflated in 2026 comparisons as "$149 to $199," which they are not. The compounded price is a starting price on an annual commitment. Named in Lilly's 2025 litigation.

Bottom line. A reasonable choice for a man who wants a men's-health program and either has the annual budget or wants brand-name Zepbound; ask for the price at 15 mg before paying the year.

8. Noom Med: behavioral program plus medication

Key specifications. GLP-1 Rx Plus (tirzepatide class): $149 for the first four weeks, then $299 a month billed quarterly ($897 per twelve weeks). GLP-1 Rx (semaglutide class): $129 then $249 quarterly. Brand-medication telehealth: $39 then $99 a month, medication excluded. Owns Tailor Made Compounding, a 503A pharmacy operating in 46 states. Verified against noom.com on August 25, 2026.

Pros. The Noom behavioral program and app bundled with medication; an in-house 503A pharmacy; a cheap first month. Cons. Twelve-week billing cycles are the commitment; $299 a month ongoing is in the upper half of the market; not available in every state. Owning a pharmacy does not mean every prescription is filled there.

Bottom line. For a patient who wants structured behavior change as much as the drug, Noom's bundle is coherent and priced accordingly.

9. Telos RX: the $99 that became $139

Key specifications. Long-plan lower-bound pricing of about $139 a month for injectable tirzepatide and $116 for a microdose track; month-to-month and higher-dose prices not published; 503A fulfilment stated, pharmacy not named. Verified as a long-plan floor on August 25, 2026.

Pros. A long-plan floor equal to NexLife's 12-month rate. Cons. The $99 and $69 figures that put Telos at the top of August 2026 directories were introductory claims, not ongoing prices; the fee structure, dose policy and pharmacy are all unpublished, so the row carries every flag we have.

Bottom line. Price-first patients should get the all-in cost at 15 mg, the plan length behind the $139, and the pharmacy name in writing before treating this as a $139 provider.

10. Ivím Health: prepaid bundles plus membership

Key specifications. Tirzepatide $1,100 for six months ($183 a month) or $900 for four months ($225); semaglutide $600 for six months ($100) or $499 for four; membership $75 a month with a first-month promotion. Verified against ivimhealth.com on August 25, 2026. State availability varies; pharmacies not named.

Pros. Provider visits, coaching and app tracking inside the membership; a six-month semaglutide bundle that is competitive at $175 all-in. Cons. No month-to-month medication price; the "starting at $133" language is a promotional equivalent; $258 a month all-in for tirzepatide is in the upper half of the market.

Bottom line. A membership-model alternative to Mochi with prepaid medication; compare the all-in monthly figures rather than the bundle prices.

Best compounded tirzepatide for specific needs

Without insurance. Insurance does not cover compounded GLP-1s, so every ranked provider is cash-pay; the question is which price includes the consult and shipping and does not move after month one. NexLife ($139 to $169, all-in, locked), Trimi ($125 annual), BMI MD (reported $139 to $179, all-in), Orderly ($299, all-in) and TelePep ($249, no commitment) qualify. If you have coverage for Zepbound, none of them beats a copay; use Ro or your own clinician.

Without a subscription or membership. NexLife $169 (30 days' notice), TelePep $249 (no commitment), GobyMeds $299 for a single month at any dose, Remedy $399 after a $279 first month, and Mochi at $278 all-in with cancel-anytime terms. Read the notice period before paying; "cancel anytime" and "cancel before the next cycle" are different sentences.

Cheapest over a year. Trimi $1,500, then NexLife, Telos RX and BMI MD at $1,668, CoreAge Rx $1,788, Sunlight $1,884 (assumption flagged), HealthRX $2,148, Ozari $2,166. The cheapest compounded tirzepatide guide works through each in prose.

From a named 503A pharmacy. Orderly (five named), Lavender Sky (thirteen named, priced individually), Trimi (two), Ozari (two), Peak Wellness (four), Zappy (one), Noom (its own), Fifty 410 (two). IvyRx is reported to use a 503B partner but its pricing is unclear; we have not found a ranked provider that guarantees 503B dispensing.

The providers we list but do not rank, and why

Henry Meds lists no injectable compounded tirzepatide on its program page (its tirzepatide is an oral form at $349 a month). Shed's product page and terms disagree. Fridays shows four irreconcilable prices on one page. Ageless is two businesses. ReflexMD advertises "$92" without a period. IvyRx cites $175 with unclear terms. Wellorithm quotes after intake. Lavender Sky prices by pharmacy across dozens of tiers. Hims, Hers, LifeMD, Calibrate, WeightWatchers Clinic and Noom's brand plan sell memberships with medication billed separately. Each has a provider page saying exactly what was and was not found, and each enters the ranking automatically when a price is verified.

The brand-name route, for comparison

Zepbound vials through LillyDirect cost $299 at 2.5 mg, $399 at 5 mg and $449 at 7.5 to 15 mg under Lilly's Self Pay Journey offer, with $499 and $699 regular prices if the refill window is missed and terms stated through December 31, 2026; the year is about $4,938 on our model before any clinical fee. Against compounded plans at $125 to $170 a month the gap is roughly $3,300 a year; against compounded plans at $300 to $400 a month it is a few hundred dollars, and the approved product comes in a pen with a fixed dose and no arithmetic. If your compounded quote is above $300 a month, run the brand comparison before signing.

Final word

The best compounded tirzepatide provider in 2026 is the one whose price you can predict for a year and whose pharmacy you can name. On our data that is NexLife for most patients, Trimi for patients who will prepay a year, and Orderly or Mochi for patients who value disclosure or clinical contact over the last $100 a month. Whichever you choose, ask three questions in writing before paying: the all-in price at 15 mg, the pharmacy and its license in your state, and the notice period to leave. The answers are worth more than any ranking, including this one.

Sources

1. Provider plan and pricing pages for every ranked provider, checked August 25, 2026 (URLs on each provider page and in the pricing database).
2. FDA. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (adverse-event counts as of May 31, 2026).
3. FDA. Clarification of FDA's Determination on the Tirzepatide Shortage, December 19, 2024; compounding guidance under sections 503A and 503B.
4. Eli Lilly. Zepbound coverage and savings page (Self Pay Journey vial pricing), accessed August 25, 2026.
5. Jastreboff AM et al. SURMOUNT-1. N Engl J Med 2022;387:205-216.
6. Aronne LJ et al. SURMOUNT-5. N Engl J Med 2025.
7. Policy Lab. Best Online Tirzepatide Compounding Providers Compared for 2026 (updated August 19, 2026), used as a reported source for BMI MD, TrimRx, Raeliva, ReflexMD, MyStartHealth and IvyRx pending direct verification.

Citations are to primary sources (peer-reviewed trials, FDA labeling and announcements, and provider pricing pages). See our sources policy and corrections log.